Innoxel Lifesciences Private Limited - Company Profile

It is a chemicals and materials private limited company based in Baroda, Gujarat, India, established in 2020.
2020 Baroda, Gujarat, India Active
Last Updated:
Access Report
About Innoxel Lifesciences Private Limited

Innoxel Lifesciences Private Limited, a active private limited company, was established on 16 October 2020 in Baroda, Gujarat, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds CIN: U24290GJ2020PTC117407. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹105.00 Cr and a paid-up capital of ₹100.00 Cr.

It upholds a compliant status. Employing 117 professional, Its leadership includes Mukeshbhai Jivrajbhai Patel (Director), Bharatkumar Rameshchandra Desai (Whole-Time Director), Bhahim Bharatkumar Desai (Director). Past directors included Mukeshbhai Jivrajbhai Patel, Shyam Singh Rajpurohit, Zankhana Bimalkumar Sheth. It holds ₹124.70 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Survey No.144 /146, Po.Hari Pura Tal, Savli, Dist-Baroda, Baroda, Gujarat, 391520.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290GJ2020PTC117407

  • Registration Number

    117407

  • Incorporation Date

    16 October 2020

  • Authorized Capital

    ₹105.00 Cr

  • Paid-Up Capital

    ₹100.00 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 105.00 Cr
  • Paid Up Capital ₹ 100.00 Cr
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 124.70 Cr
  • Revenue Growth **** 8545.45%
  • Profit Growth **** -168.12%
  • Ebitda **** -174.07%
  • Net Worth 672.34%
  • Total Assets **** 234.94%
Company report

Innoxel Lifesciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Innoxel Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Innoxel Lifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Mukeshbhai Jivrajbhai Patel Director 01 Sep 2023 Current
Bharatkumar Rameshchandra Desai Whole-Time Director 16 Oct 2020 Current
Bhahim Bharatkumar Desai Director 16 Oct 2020 Current
Puspaben Fulashankerbhai Trivedi Director 16 Oct 2020 Current
Himaben Bharatkumar Desai Director 16 Oct 2020 Current
Zankhana Bimalkumar Sheth Director 01 Sep 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 01 Jul 2024 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 01 Jul 2024 Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Innoxel Lifesciences.

Innoxel Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 8545.45% increase. The company also saw a substantial fall in profitability, with a 168.12% decrease in profit. The company's net worth Soared by an impressive increase of 672.34%.

Innoxel Lifesciences revenue growth over time
Innoxel Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 8545.45%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 234.94%
*******
*******
*******
*******
Profit or Loss
*******
 -168.12%
*******
*******
*******
*******
Net Worth
*******
 672.34%
*******
*******
*******
*******
EBITDA
*******
 -174.07%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Innoxel Lifesciences?

In 2023, Innoxel Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,247,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 124.50 Cr
  • Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
20 Dec 2023 Hdfc Bank Limited ₹2.00 M Open
31 Mar 2023 Axis Bank Limited ₹124.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Innoxel Lifesciences?

Innoxel Lifesciences has a workforce of 117 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Innoxel Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innoxel Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Innoxel Lifesciences
Recent Activity within the Organization
  • Annual General Meeting

    The activity Innoxel Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 124.50 Cr registered on 31 Mar 2023 with Charge ID 100708829 was modified on 04 Jun 2025. was completed.

  • Director Appointment

    Sharmin Nareshkumar Soni was appointed as a Company Secretary was appointed as a Company Secretary on 07 May 2025 & has been associated with this company since 9 months 23 days . was recorded as a recent event.

  • Balance Sheet

    The activity Innoxel Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100840371 was registered on 20 Dec 2023. was documented.

  • Director Appointment

    Mukeshbhai Jivrajbhai Patel was appointed as a Director was appointed as a Director on 01 Sep 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Innoxel Lifesciences Private Limited?

The CIN of Innoxel Lifesciences Private Limited is U24290GJ2020PTC117407.

Where is Innoxel Lifesciences Private Limited headquartered?

Innoxel Lifesciences Private Limited is headquartered at Survey No.144 /146, Po.Hari Pura Tal, Savli, Dist-Baroda, Baroda, Gujarat, 391520.

When was Innoxel Lifesciences Private Limited incorporated?

Innoxel Lifesciences Private Limited was incorporated on 16 October 2020.

Who are the current directors of Innoxel Lifesciences Private Limited?

The current directors of Innoxel Lifesciences Private Limited are

What is the primary industry of Innoxel Lifesciences Private Limited?

The primary industry of Innoxel Lifesciences Private Limited is Chemicals And Materials.

Is Innoxel Lifesciences Private Limited a listed company?

Innoxel Lifesciences Private Limited is unlisted.

What is the capital structure of Innoxel Lifesciences Private Limited?

The authorized capital of Innoxel Lifesciences Private Limited is ₹105.00 Cr, and the paid-up capital is ₹100.00 Cr.

What is the compliance status of Innoxel Lifesciences Private Limited?

The compliance status of Innoxel Lifesciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available